CEP-701 (Lestaurtinib) in Myelofibrosis

NCT00668421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis
Essential Thrombocythemia
Polycythemia Vera

Interventions

DRUG: CEP-701 (Lestaurtinib)

Sponsor

Ronald Hoffman

Collaborators

[object Object]
[object Object]